Search

Your search keyword '"Graham, William S."' showing total 5 results
Start Over Author "Graham, William S."
5 results on '"Graham, William S."'

1. NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE

Author

Hope, Thomas A., primary, Abbott, Amanda, additional, Colucci, Karen, additional, Bushnell, David L., additional, Gardner, Linda, additional, Graham, William S., additional, Lindsay, Sheila, additional, Metz, David C., additional, Pryma, Daniel A., additional, Stabin, Michael G., additional, and Strosberg, Jonathan R., additional

Published
2019
Full Text
View/download PDF

2. Nitride etching with hydrofluorocarbons. I. Selective etching of nitride over silicon and oxide materials by gas discharge optimization and selective deposition of fluorocarbon polymer

Author

Engelmann, Sebastian U., primary, Bruce, Robert L., additional, Joseph, Eric A., additional, Fuller, Nicholas C. M., additional, Graham, William S., additional, Sikorski, Edmund M., additional, Kohjasteh, Mahmoud, additional, Zhu, Yu, additional, Nakamura, Masahiro, additional, Ito, Azumi, additional, Matsumoto, Hirokazu, additional, Matsuura, Goh, additional, and Suzuki, Takefumi, additional

Published
2017
Full Text
View/download PDF

4. Electroless Deposition of NiB on 15 Inch Glass Substrates for the Fabrication of Transistor Gates for Liquid Crystal Displays

Author

Delamarche, Emmanuel, primary, Geissler, Matthias, additional, Vichiconti, James, additional, Graham, William S., additional, Andry, Paul A., additional, Flake, John C., additional, Fryer, Peter M., additional, Nunes, Ronald W., additional, Michel, Bruno, additional, O'Sullivan, Eugene J., additional, Schmid, Heinz, additional, Wolf, Heiko, additional, and Wisnieff, Robert L., additional

Published
2003
Full Text
View/download PDF

5. NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE.

Author

Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, and Strosberg JR

Subjects
Bone Marrow radiation effects, Humans, Kidney radiation effects, Octreotide administration & dosage, Octreotide adverse effects, Octreotide therapeutic use, Organometallic Compounds administration & dosage, Organometallic Compounds adverse effects, Organs at Risk radiation effects, Radiometry, Reference Standards, Safety, Neuroendocrine Tumors radiotherapy, Nuclear Medicine, Octreotide analogs & derivatives, Organometallic Compounds therapeutic use, Receptors, Somatostatin metabolism, Societies, Medical standards
Abstract

With the recent approval of 177 Lu-DOTATATE for use in gastroenteropancreatic neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing. Representatives from the North American Neuroendocrine Tumor Society and the Society of Nuclear Medicine and Molecular Imaging collaborated to develop a practical consensus guideline for the administration of 177 Lu-DOTATATE. In this paper, we discuss patient screening, maintenance somatostatin analog therapy requirements, treatment location and room preparation, drug administration, and patient release as well as strategies for radiation safety, toxicity monitoring, management of potential complications, and follow-up. Controversies regarding the role of radiation dosimetry are discussed as well. This document is designed to provide practical guidance on how to safely treat patients with this therapy., (© 2019 by the Society of Nuclear Medicine and Molecular Imaging.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results